Category: Federal Forum Posters
Purpose: It is estimated that 45-51% of pregnancies are unplanned in the United States, with Idaho having 12,000 unintended pregnancies annually. With the increasing number of women Veterans at the Boise VA Medical Center (BVAMC), ensuring safe use of medications in women of reproductive age is critical. A previous evaluation assessed the utilization of contraceptive methods among women Veterans aged ≤45 years on a teratogenic medication at the BVAMC, finding that 24% were not preventing pregnancy. This evaluation is intended to assess pregnancy-related outcomes of female Veterans not preventing pregnancy and to implement pharmacist interventions to prevent adverse outcomes.
Methods: This retrospective cohort evaluation will assess the outcomes of female Veterans identified from the previous analysis, in addition to women identified from the end of the previous study date, until 10/01/2018. The following information will be obtained on all subjects: current medications and indications, if the teratogen has been switched or discontinued (by patient or provider), documentation of military sexual trauma, current method of pregnancy prevention, and pregnancy status. For women identified as pregnant, the following will be obtained: timing of teratogen exposure, prenatal vitamin, pregnancy history, the number of live births, miscarriages, abortions, and stillbirths, and whether or not the teratogenic medication was acknowledged by a provider (e.g. consult entered to women’s health pharmacist or OB/GYN). For live births, the number of births with a teratogenic outcome will be obtained, including premature birth, NICU admission, type of malformation, withdrawal symptoms, or other adverse outcome in the neonate, as well as the presence of adverse maternal outcomes. Secondary outcomes include assessment of pharmacist intervention including teratogen and contraception counseling, and if appropriate, initiation of a contraceptive method. Each patient will be contacted via telephone. An IRB approval was not required for this evaluation.
Results: not applicable
Conclusion: not applicable
Audra Wilson– PGY2 Ambulatory Care Pharmacy Resident, Boise VA Medical Center, Boise, ID